8-K - BioCardia, Inc. (0000925741) (Filer)

US · 2026-09-21

1. Step 1 · The triggerBioCardia's share price closes at or above $1.00 for 10 consecutive business days, meeting Nasdaq's minimum bid price rule.
2. Step 2 · Knock-onNasdaq removes the delisting threat, restoring BioCardia's continued listing status and reducing the need for capital-structure remedies that could dilute shareholders.
3. Step 3 · Knock-onWith listing status secured, BioCardia maintains access to public equity markets, stabilizing its financing options and signaling operational continuity to suppliers and partners.
4. Step 4 · Reaches youUS SMEs in similar situations can avoid unnecessary dilution or restructuring by monitoring compliance and awaiting formal exchange determinations before acting.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: SEC EDGAR — Current filings

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.